Publication: Fast and Simultaneous Analysis of Combined Anti-Diabetic Drugs by Capillary Zone Electrophoresis
Issued Date
2015-01-01
Resource Type
ISSN
00219665
Other identifier(s)
2-s2.0-84938881986
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Chromatographic Science. Vol.53, No.6 (2015), 993-999
Suggested Citation
Athiporn Doomkaew, Pornpan Prapatpong, Sawanya Buranphalin, Yvan Vander Heyden, Leena Suntornsuk Fast and Simultaneous Analysis of Combined Anti-Diabetic Drugs by Capillary Zone Electrophoresis. Journal of Chromatographic Science. Vol.53, No.6 (2015), 993-999. doi:10.1093/chromsci/bmu138 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35773
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Fast and Simultaneous Analysis of Combined Anti-Diabetic Drugs by Capillary Zone Electrophoresis
Other Contributor(s)
Abstract
© 2014 The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. A fast capillary zone electrophoretic method with photodiode array detection (CZE-PAD) was established and validated for assays of commonly prescribed anti-diabetic drugs [metformin (MET), glibenclamide (GBM) and gliclazide (GCZ)] in 13 samples including raw material, single and combined tablets. CZE optimization revealed baseline separation of the analytes (R<inf>s</inf> > 5.39) in 8 min, in 50 mM borate buffer (pH 9.0), using a capillary with an effective length of 56.0 cm and an inner diameter of 50 μm, a voltage of 20 kV, a temperature of 25°C and a detection wavelength at 210 nm. The method provides excellent linearity, precision (%RSDs < 1.90%), recovery (99.8-101.0%) and low detection and quantitation limits (<4 and 12 μg/mL, respectively). The procedure was fast (seven samples per hour) and cost effective, since no organic solvent, sample pre-treatments or clean-up procedures were required. Importantly, the method was accurate, sensitive and reliable for routine quality control of MET, GBM and GCZ in pharmaceutical products both in single and combined formulations.